236 related articles for article (PubMed ID: 11082412)
1. Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms.
Sato M; Engelman RM; Otani H; Maulik N; Rousou JA; Flack JE; Deaton DW; Das DK
Circulation; 2000 Nov; 102(19 Suppl 3):III346-51. PubMed ID: 11082412
[TBL] [Abstract][Full Text] [Related]
2. Effects of the angiotensin II subtype 1 receptor antagonist losartan on functional recovery of isolated rat hearts undergoing global myocardial ischemia-reperfusion.
Flynn JD; Akers WS
Pharmacotherapy; 2003 Nov; 23(11):1401-10. PubMed ID: 14620386
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts.
Zhu P; Zaugg CE; Hornstein PS; Allegrini PR; Buser PT
J Cardiovasc Pharmacol; 1999 May; 33(5):785-90. PubMed ID: 10226867
[TBL] [Abstract][Full Text] [Related]
4. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
5. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
6. Intermittent losartan administration triggers cardiac post-conditioning in isolated rat hearts: role of BK2 receptors.
Sgarra L; Leo V; Addabbo F; Iacobazzi D; Carratù MR; Montagnani M; Potenza MA
PLoS One; 2014; 9(2):e88542. PubMed ID: 24520397
[TBL] [Abstract][Full Text] [Related]
7. The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signaling.
Bonde MM; Olsen KB; Erikstrup N; Speerschneider T; Lyngsø C; Haunsø S; Nielsen MS; Sheikh SP; Hansen JL
Regul Pept; 2011 Feb; 167(1):21-5. PubMed ID: 21115072
[TBL] [Abstract][Full Text] [Related]
8. Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA.
Yang BC; Phillips MI; Zhang YC; Kimura B; Shen LP; Mehta P; Mehta JL
Circ Res; 1998 Sep; 83(5):552-9. PubMed ID: 9734478
[TBL] [Abstract][Full Text] [Related]
9. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts.
Goto M; Liu Y; Yang XM; Ardell JL; Cohen MV; Downey JM
Circ Res; 1995 Sep; 77(3):611-21. PubMed ID: 7641331
[TBL] [Abstract][Full Text] [Related]
10. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
Wang QD; Sjöquist PO
Eur J Pharmacol; 1999 Sep; 380(1):13-21. PubMed ID: 10513555
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart.
Bugge E; Ytrehus K
J Mol Cell Cardiol; 1996 Dec; 28(12):2333-41. PubMed ID: 9004150
[TBL] [Abstract][Full Text] [Related]
12. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
[TBL] [Abstract][Full Text] [Related]
13. Effects of the angiotensin AT1 receptor blocker candesartan on myocardial ischemic/reperfusion injury.
Shimizu M; Sjöquist PO; Wang QD; Rydén L
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S137-42. PubMed ID: 9892154
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin is a mediator, but unlikely a trigger, of antiarrhythmic effects of ischemic preconditioning.
Driamov SV; Bellahcene M; Butz S; Buser PT; Zaugg CE
J Cardiovasc Electrophysiol; 2007 Jan; 18(1):93-9. PubMed ID: 17229306
[TBL] [Abstract][Full Text] [Related]
15. Role of ceramide in ischemic preconditioning.
Cui J; Engelman RM; Maulik N; Das DK
J Am Coll Surg; 2004 May; 198(5):770-7. PubMed ID: 15110811
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin mediates myocardial ischaemic preconditioning against free radical injury in guinea-pig isolated heart.
Jin ZQ; Chen X
Clin Exp Pharmacol Physiol; 1998 Nov; 25(11):932-5. PubMed ID: 9807666
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin mediates cardiac preconditioning at a distance.
Schoemaker RG; van Heijningen CL
Am J Physiol Heart Circ Physiol; 2000 May; 278(5):H1571-6. PubMed ID: 10775135
[TBL] [Abstract][Full Text] [Related]
18. Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.
Koid SS; Ziogas J; Campbell DJ
Hypertension; 2014 Apr; 63(4):768-73. PubMed ID: 24420538
[TBL] [Abstract][Full Text] [Related]
19. Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart.
Weinbrenner C; Schulze F; Sárváry L; Strasser RH
Cardiovasc Res; 2004 Feb; 61(3):591-9. PubMed ID: 14962489
[TBL] [Abstract][Full Text] [Related]
20. AT1-receptor blockade enhances ischemic preconditioning in hypertrophied rat myocardium.
Butler KL; Huang AH; Gwathmey JK
Am J Physiol; 1999 Dec; 277(6):H2482-7. PubMed ID: 10600872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
